Growth factors in gliomas: antisense and dominant negative mutant strategies.

作者: Jeffrey W. Campbell , Ian F. Pollack

DOI: 10.1023/A:1005820701709

关键词:

摘要: Antisense and dominant negative mutant strategies were developedas 'magic bullets' to suppress the function ofa particular gene while preserving remaining cellularactivities. While experience with these techniques has dispelledsome of 'magic', remain usefulfor understanding products.Antisense involve administration either asynthetic oligodeoxy-nucleotide or a plasmid construct which producesa sequence that is complementary DNAor mRNA interest. Antisensebinding should inhibit transcription translation thegene, thus decrease synthesis proteinfor encodes. Conversely, negativemutations activity product byencoding for second protein suppresses thefunction For example,a single subunit in multimeric proteinmight allow normal assembly whileinhibiting its activity. The use techniquesfor investigating role various growth factorpathways glial neoplasia their potential therapeuticapplications are reviewed below.

参考文章(53)
S M Shamah, C D Stiles, A Guha, Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Molecular and Cellular Biology. ,vol. 13, pp. 7203- 7212 ,(1993) , 10.1128/MCB.13.12.7203
H. Kimura, Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 2165- 2169 ,(1993) , 10.1073/PNAS.90.6.2165
H. Ohgaki, P. Kleihues, B. Schäuble, A. zur Hausen, K. von Ammon, Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Archiv. ,vol. 427, pp. 113- 118 ,(1995) , 10.1007/BF00196514
L. Whitesell, D. Geselowitz, C. Chavany, B. Fahmy, S. Walbridge, J. R. Alger, L. M. Neckers, Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 4665- 4669 ,(1993) , 10.1073/PNAS.90.10.4665
Carl-Henrik HELDIN, Bengt WESTERMARK, Growth factors as transforming proteins. FEBS Journal. ,vol. 184, pp. 487- 496 ,(1989) , 10.1111/J.1432-1033.1989.TB15041.X
Gordon H. Baltuch, Nora P. Dooley, Klara M. Rostworowski, Jean -Guy Villemure, Voon Wee Yong, Protein kinase C isoform ? overexpression in C6 glioma cells and its role in cell proliferation Journal of Neuro-Oncology. ,vol. 24, pp. 241- 250 ,(1995) , 10.1007/BF01052840
Karl H. Plate, Werner Risau, Angiogenesis in malignant gliomas Glia. ,vol. 15, pp. 339- 347 ,(1995) , 10.1002/GLIA.440150313
Gary J. Redekop, Christian C. G. Naus, Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. Journal of Neurosurgery. ,vol. 82, pp. 83- 90 ,(1995) , 10.3171/JNS.1995.82.1.0083
P. C. Zamecnik, M. L. Stephenson, Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide Proceedings of the National Academy of Sciences of the United States of America. ,vol. 75, pp. 280- 284 ,(1978) , 10.1073/PNAS.75.1.280